BCDA insider filings
BioCardia, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-30. Screen BCDA transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 9 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 12 legs across 9 filings by 1 insider — 28,300 shares, $25,911 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 5,500 shares @ $0.97 ($5,335) by Altman Peter, filed 2026-07-10.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Altman Peter — President and CEO, Director | 9 | 12 legs · 28,300 sh · $25,911 | — | — |
Recent insider filings — BioCardia, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,000 @ $1.03 | EDGAR |
| 2026-09-23 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,900 @ $1.05 | EDGAR |
| 2026-09-04 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 800 @ $1.09 | EDGAR |
| 2026-08-18 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,400 @ $0.93 | EDGAR |
| 2026-08-13 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,900 @ $0.92 | EDGAR |
| 2026-07-29 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,000 @ $0.78 | EDGAR |
| 2026-07-20 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 500 @ $0.83 | EDGAR |
| 2026-07-15 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 2,800 @ $0.88 · Purchase (P): 1,500 @ $0.86 | EDGAR |
| 2026-07-10 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,500 @ $0.97 · Purchase (P): 1,000 @ $0.90 · Purchase (P): 1,000 @ $0.94 | EDGAR |
| 2026-07-08 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,400 @ $0.96 | EDGAR |
| 2026-07-07 | 4 | Facteau Bill — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Slosman Marvin — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Blank Andrew Scott — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Allen Jim L. — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | McClung David — Chief Financial Officer | Tax withholding (F): 23,125 @ $1.24 · Grant/award (A): 41,501 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Altman Peter — President and CEO, Director | Tax withholding (F): 54,606 @ $1.24 · Grant/award (A): 57,688 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | GILLIS EDWARD M — Senior Vice President, Devices | Tax withholding (F): 17,269 @ $1.24 · Grant/award (A): 29,442 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | MOYES JAY M — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | STERTZER SIMON H — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | McClung David — Chief Financial Officer | Grant/award (A): 60,483 @ $1.20 | EDGAR |
| 2026-07-01 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 110,625 @ $1.20 | EDGAR |
| 2026-07-01 | 4 | GILLIS EDWARD M — Senior Vice President, Devices | Grant/award (A): 39,521 @ $1.20 | EDGAR |
| 2026-06-24 | 4 | STERTZER SIMON H — Director | Purchase (P): 70,200 @ $0.92 · Purchase (P): 39,000 @ $1 | EDGAR |
| 2026-06-22 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,500 @ $0.85 · Purchase (P): 800 @ $0.96 | EDGAR |
| 2026-06-09 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,000 @ $0.85 | EDGAR |
| 2026-05-21 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 200 @ $0.95 · Purchase (P): 1,500 @ $0.92 | EDGAR |
| 2026-05-18 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,700 @ $0.92 | EDGAR |
| 2026-05-15 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,100 @ $1.02 | EDGAR |
| 2026-04-29 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,000 @ $1.11 | EDGAR |
| 2026-04-22 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 600 @ $1.23 · Purchase (P): 400 @ $1.23 | EDGAR |
| 2026-03-26 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 600 @ $1.24 · Purchase (P): 300 @ $1.22 | EDGAR |
| 2026-02-04 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 5,000 @ $1.13 | EDGAR |
| 2026-01-21 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 600 @ $1.32 · Purchase (P): 300 @ $1.34 | EDGAR |
| 2025-12-17 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 200 @ $1.37 · Purchase (P): 900 @ $1.30 | EDGAR |
| 2025-12-10 | 4 | Facteau Bill — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Slosman Marvin — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Blank Andrew Scott — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Allen Jim L. — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | McClung David — Chief Financial Officer | Grant/award (A): 58,276 @ $1.37 · Tax withholding (F): 29,339 @ $1.37 · Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Altman Peter — President and CEO, Director | Grant/award (A): 106,588 @ $1.37 · Tax withholding (F): 56,484 @ $1.37 · Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | GILLIS EDWARD M — Senior Vice President, Devices | Grant/award (A): 38,078 @ $1.37 · Tax withholding (F): 15,172 @ $1.37 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | MOYES JAY M — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | STERTZER SIMON H — Director | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-09-23 | 4 | Blank Andrew Scott — Director | Purchase (P): 288,000 @ $1.25 · Purchase (P): 288,000 (derivative) | EDGAR |
| 2025-09-23 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 48,000 @ $1.25 · Purchase (P): 48,000 (derivative) | EDGAR |
| 2025-09-23 | 4 | STERTZER SIMON H — Director | Purchase (P): 398,400 @ $1.25 · Purchase (P): 398,400 (derivative) | EDGAR |
| 2025-08-25 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 700 @ $1.83 | EDGAR |
| 2025-08-13 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 100 @ $1.83 | EDGAR |
| 2025-08-12 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 400 @ $1.75 | EDGAR |
| 2025-08-11 | 4 | Altman Peter — President and CEO, Director | Purchase (P): 1,700 @ $1.76 | EDGAR |
Recent 8-K events — BioCardia, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-21 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BCDA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →